Management of HER2+ Breast Cancer After pCR
Management of HER2+ Breast Cancer After pCR
Created using ChatSlide
This keynote presentation delves into the intricacies of achieving pathologic complete response (pCR) in HER2-positive breast cancer and its pivotal role in shaping treatment pathways and prognostic outcomes. We will explore current protocols, innovative targeted therapies, and comprehensive patient monitoring strategies following pCR. The talk will address challenges such as treatment resistance and the importance of personalised patient care. Attendees will gain insights into the latest...